$1.68 Billion is the total value of SABBY MANAGEMENT, LLC's 312 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 98.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SPDR S&P 500put | $519,300,000 | – | 19,734 | +100.0% | 31.00% | – | |
| Buy | ASTRAZENECA PLCcall | $102,428,000 | +97.5% | 29,290 | +96.0% | 6.11% | +29.5% | |
| BIIB | New | BIOGEN INC | $100,162,000 | – | 365,796 | +100.0% | 5.98% | – |
| Buy | BIOGEN INCput | $97,856,000 | +11032.7% | 4,142 | +1700.9% | 5.84% | +7201.2% | |
| Buy | ESPERION THERAPEUTICS INCput | $87,562,000 | +696.4% | 12,106 | +624.9% | 5.23% | +422.2% | |
| New | ISHARES RUSSELL 2000put | $87,302,000 | – | 5,750 | +100.0% | 5.21% | – | |
| Buy | ISHARES RUSSELL 2000call | $75,916,000 | +18.4% | 5,000 | +18.9% | 4.53% | -22.4% | |
| Buy | ASTRAZENECA PLCput | $58,610,000 | +124.9% | 16,760 | +123.1% | 3.50% | +47.4% | |
| Sell | SAREPTA THERAPEUTICS INCcall | $34,570,000 | -31.1% | 4,666 | -48.3% | 2.06% | -54.9% | |
| Buy | ZOGENIX INCcall | $32,512,000 | +162.7% | 8,118 | +162.7% | 1.94% | +72.2% | |
| ODT | Buy | ODONATE THERAPEUTICS INC | $31,104,000 | +50.7% | 1,468,544 | +77.9% | 1.86% | -1.2% |
| Sell | MERCK & CO INCcall | $27,126,000 | -73.5% | 4,980 | -72.7% | 1.62% | -82.7% | |
| SPY | New | SPDR S&P 500tr | $23,420,000 | – | 89,000 | +100.0% | 1.40% | – |
| Buy | INCYTE CORPput | $21,582,000 | +120.0% | 2,590 | +150.0% | 1.29% | +44.1% | |
| New | SPDR S&P BIOTECHput | $19,686,000 | – | 2,244 | +100.0% | 1.18% | – | |
| Buy | INCYTE CORPcall | $19,000,000 | +277.1% | 2,280 | +328.6% | 1.13% | +147.1% | |
| Buy | NEKTAR THERAPEUTICScall | $15,408,000 | +363.3% | 1,450 | +160.3% | 0.92% | +203.6% | |
| INCY | New | INCYTE CORP | $13,642,000 | – | 163,722 | +100.0% | 0.81% | – |
| New | SPARK THERAPEUTICS INCput | $13,518,000 | – | 2,030 | +100.0% | 0.81% | – | |
| Buy | ALEXION PHARMACEUTICALS INCcall | $13,220,000 | +347.5% | 1,186 | +380.2% | 0.79% | +193.3% | |
| Buy | SAREPTA THERAPEUTICS INCput | $13,158,000 | +60.7% | 1,776 | +20.7% | 0.78% | +5.2% | |
| Buy | SANGAMO THERAPEUTICS INCput | $12,866,000 | +187.4% | 6,772 | +148.1% | 0.77% | +88.2% | |
| NKTR | Buy | NEKTAR THERAPEUTICS | $12,502,000 | +947.1% | 117,662 | +488.3% | 0.75% | +584.4% |
| UMRX | New | UNUM THERAPEUTICS INC | $12,292,000 | – | 1,106,445 | +100.0% | 0.73% | – |
| New | SPARK THERAPEUTICS INCcall | $10,322,000 | – | 1,550 | +100.0% | 0.62% | – | |
| Sell | ALKERMES PLCcall | $7,836,000 | -10.5% | 1,352 | -15.4% | 0.47% | -41.3% | |
| Buy | ESPERION THERAPEUTICS INCcall | $7,782,000 | +928.0% | 1,076 | +835.7% | 0.46% | +573.9% | |
| New | GLOBAL BLOOD THERAPEUTICS INCcall | $7,322,000 | – | 1,516 | +100.0% | 0.44% | – | |
| RKDA | New | ARCADIA BIOSCIENCES INC | $7,222,000 | – | 300,752 | +100.0% | 0.43% | – |
| Buy | ABBVIE INCcall | $6,986,000 | +2786.8% | 738 | +2852.0% | 0.42% | +1795.5% | |
| Sell | ALNYLAM PHARMACEUTICALS INCput | $5,956,000 | -70.8% | 500 | -68.8% | 0.36% | -80.8% | |
| New | NEKTAR THERAPEUTICSput | $5,950,000 | – | 560 | +100.0% | 0.36% | – | |
| Buy | ZOGENIX INCput | $5,502,000 | +23.3% | 1,374 | +23.3% | 0.33% | -19.2% | |
| SGMO | New | SANGAMO THERAPEUTICS INC | $5,402,000 | – | 284,272 | +100.0% | 0.32% | – |
| Buy | AMARIN CORP PLCcall | $5,008,000 | +416.3% | 16,638 | +588.1% | 0.30% | +239.8% | |
| Buy | AVEO PHARMACEUTICALS INCcall | $4,972,000 | +14523.5% | 17,142 | +13950.8% | 0.30% | +9800.0% | |
| New | ACCELERON PHARMA INCput | $4,098,000 | – | 1,048 | +100.0% | 0.24% | – | |
| CTXR | Buy | CITIUS PHARMACEUTICALS INC | $3,976,000 | +384.9% | 1,282,402 | +510.3% | 0.24% | +216.0% |
| Buy | AMYRIS INCput | $3,774,000 | +3914.9% | 5,642 | +2156.8% | 0.22% | +2400.0% | |
| ONS | Buy | ONCOBIOLOGICS INC | $3,752,000 | +38.8% | 4,216,498 | +102.8% | 0.22% | -8.9% |
| New | ACHAOGEN INCput | $3,638,000 | – | 2,810 | +100.0% | 0.22% | – | |
| Sell | BRISTOL MYERS SQUIBBput | $3,554,000 | -98.3% | 562 | -98.4% | 0.21% | -98.9% | |
| CANF | New | CAN FITE BIOPHARMA LTDadr | $3,536,000 | – | 2,456,182 | +100.0% | 0.21% | – |
| SLNO | Buy | SOLENO THERAPEUTICS | $3,322,000 | +101.7% | 1,835,670 | +100.6% | 0.20% | +32.0% |
| NOVN | New | NOVAN INC | $3,194,000 | – | 1,090,298 | +100.0% | 0.19% | – |
| APOP | New | CELLECT BIOTECHNOLOGY LTDads | $3,114,000 | – | 487,960 | +100.0% | 0.19% | – |
| Sell | AMICUS THERAPEUTICS INCcall | $3,024,000 | -79.7% | 2,010 | -80.6% | 0.18% | -86.7% | |
| AMICUS THERAPEUTICS INCput | $3,008,000 | +4.5% | 2,000 | 0.0% | 0.18% | -31.3% | ||
| PAVM | New | PAVMED INC | $2,980,000 | – | 1,817,634 | +100.0% | 0.18% | – |
| BMY | Sell | BRISTOL MYERS SQUIBB | $2,948,000 | -94.8% | 46,624 | -95.0% | 0.18% | -96.6% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $2,740,000 | +12.0% | 23,000 | +19.5% | 0.16% | -26.5% |
| ESPR | Sell | ESPERION THERAPEUTICS INC | $2,722,000 | -70.9% | 37,646 | -73.5% | 0.16% | -81.0% |
| Buy | PROTHENA CORPORATION PLCput | $2,672,000 | +65.3% | 862 | +100.0% | 0.16% | +8.8% | |
| EBIO | New | ELEVEN BIOTHERAPEUTICS INC | $2,574,000 | – | 2,452,234 | +100.0% | 0.15% | – |
| New | INSMED INCput | $2,446,000 | – | 1,086 | +100.0% | 0.15% | – | |
| OVAS | Buy | OVASCIENCE INC | $2,370,000 | +182.1% | 2,923,050 | +387.2% | 0.14% | +85.5% |
| ZSAN | New | ZOSANO PHARMA CORO | $2,356,000 | – | 467,558 | +100.0% | 0.14% | – |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $2,308,000 | +119.8% | 397,928 | +32.6% | 0.14% | +43.8% |
| VSAR | Buy | VERSARTIS INC | $2,318,000 | +6.1% | 1,404,728 | +41.4% | 0.14% | -30.7% |
| Buy | ALEXION PHARMACEUTICALS INCput | $2,140,000 | +86.4% | 192 | +100.0% | 0.13% | +21.9% | |
| SLS | New | SELLAS LIFE SCIENCES GROUP INC | $2,134,000 | – | 618,414 | +100.0% | 0.13% | – |
| NURO | Buy | NEUROMETRIX INC | $2,004,000 | +546.5% | 1,420,778 | +689.2% | 0.12% | +328.6% |
| ADOM | New | ADOMANI INC COM | $1,990,000 | – | 1,686,814 | +100.0% | 0.12% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $1,952,000 | – | 129,820 | +100.0% | 0.12% | – |
| AKBA | New | AKEBIA THERAPEUTICS INC | $1,950,000 | – | 204,676 | +100.0% | 0.12% | – |
| New | ACHAOGEN INCcall | $1,846,000 | – | 1,426 | +100.0% | 0.11% | – | |
| Buy | ALKERMES PLCput | $1,820,000 | +42.1% | 314 | +34.2% | 0.11% | -6.8% | |
| APHB | New | AMPLIPHI BIOSCIENCES CORP | $1,814,000 | – | 1,663,922 | +100.0% | 0.11% | – |
| EYEN | New | EYENOVIA INC | $1,816,000 | – | 195,540 | +100.0% | 0.11% | – |
| Buy | SYNERGY PHARMACEUTICALS INCcall | $1,814,000 | +91.8% | 9,908 | +133.5% | 0.11% | +25.6% | |
| PRTA | Buy | PROTHENA CORPORATION PLC | $1,798,000 | +94.0% | 49,000 | +98.1% | 0.11% | +27.4% |
| OPGN | Sell | OPGEN INC | $1,750,000 | +729.4% | 1,042,152 | -7.8% | 0.10% | +447.4% |
| Buy | VERTEX PHARMACEUTICALS INCcall | $1,722,000 | -87.5% | 2,630 | +186.2% | 0.10% | -91.8% | |
| MBOT | Buy | MICROBOT MED INC | $1,686,000 | +32.2% | 2,498,800 | +99.9% | 0.10% | -12.9% |
| GLYC | New | GLYCOMIMETICS INC | $1,676,000 | – | 103,206 | +100.0% | 0.10% | – |
| CLSN | New | CELSION CORP | $1,656,000 | – | 739,720 | +100.0% | 0.10% | – |
| New | BIOGEN INCcall | $1,642,000 | – | 60 | +100.0% | 0.10% | – | |
| IDXG | Buy | INTERPACE DIAGNOSTICS GROUP | $1,624,000 | +20.7% | 1,839,708 | +39.4% | 0.10% | -21.1% |
| AFMD | New | AFFIMED INC | $1,574,000 | – | 850,926 | +100.0% | 0.09% | – |
| New | MANNKIND CORPput | $1,470,000 | – | 6,448 | +100.0% | 0.09% | – | |
| APRI | New | APRICUS BIOSCIENCES INC | $1,462,000 | – | 3,600,000 | +100.0% | 0.09% | – |
| ATNM | New | ACTINIUM PHARMACEUTICALS INC | $1,458,000 | – | 3,995,400 | +100.0% | 0.09% | – |
| HMNY | New | HELIOS &MATHESON ANALYTICS INC | $1,412,000 | – | 498,588 | +100.0% | 0.08% | – |
| SCON | New | SUPERCONDUCTOR TECHNOLOGIES | $1,386,000 | – | 1,471,760 | +100.0% | 0.08% | – |
| GALT | New | GALECTIN THERAPEUTICS INC | $1,360,000 | – | 286,800 | +100.0% | 0.08% | – |
| APDN | Sell | APPLIED DNA SCIENCES INC | $1,308,000 | -11.7% | 908,762 | -2.5% | 0.08% | -42.2% |
| Sell | MERCK & CO INCput | $1,308,000 | -91.2% | 240 | -91.0% | 0.08% | -94.3% | |
| New | DBV TECHNOLOGIES SAcall | $1,190,000 | – | 516 | +100.0% | 0.07% | – | |
| New | HELIOS &MATHESON ANALYTICS INCput | $1,162,000 | – | 4,108 | +100.0% | 0.07% | – | |
| Buy | FUELCELL ENERGY INCput | $1,140,000 | +1972.7% | 6,594 | +433.5% | 0.07% | +1260.0% | |
| EARS | New | AURIS MEDICAL HOLDING AG | $1,098,000 | – | 685,978 | +100.0% | 0.07% | – |
| PULM | New | PULMATRIX INC | $1,108,000 | – | 2,175,014 | +100.0% | 0.07% | – |
| New | ADVERUM BIOTECHNOLOGIES INCcall | $1,096,000 | – | 1,888 | +100.0% | 0.06% | – | |
| PRQR | Sell | PROQR THERAPEUTICS N V | $1,058,000 | -5.5% | 344,320 | -0.8% | 0.06% | -38.2% |
| Sell | FIBROGEN INCcall | $1,044,000 | -19.9% | 226 | -17.8% | 0.06% | -47.9% | |
| CHFS | Buy | CHF SOLUTIONS INC | $1,008,000 | +453.8% | 360,996 | +587.7% | 0.06% | +252.9% |
| MNKD | Sell | MANNKIND CORP | $920,000 | -72.6% | 403,816 | -72.1% | 0.06% | -82.0% |
| TRXC | Sell | TRANSENTERIX INC | $872,000 | -36.2% | 513,430 | -27.5% | 0.05% | -58.1% |
| Sell | SANGAMO THERAPEUTICS INCcall | $870,000 | -91.2% | 458 | -92.4% | 0.05% | -94.2% | |
| PRPO | New | PRECIPIO INC | $822,000 | – | 1,528,822 | +100.0% | 0.05% | – |
| NAOV | Buy | NANOVIBRONIX INC | $816,000 | +71.1% | 171,582 | +68.3% | 0.05% | +14.0% |
| SNES | Buy | SENESTECH INC | $810,000 | +157.1% | 1,589,480 | +263.8% | 0.05% | +65.5% |
| INPX | New | INPIXON | $788,000 | – | 733,850 | +100.0% | 0.05% | – |
| ROSGQ | New | ROSETTA GENOMICS LTD | $766,000 | – | 1,869,216 | +100.0% | 0.05% | – |
| MRK | New | MERCK & CO INC | $748,000 | – | 13,728 | +100.0% | 0.04% | – |
| Buy | SUNESIS PHARMACEUTICALS INCcall | $760,000 | +132.4% | 2,792 | +215.5% | 0.04% | +50.0% | |
| SSKN | Buy | STRATA SKIN SCIENCES INC | $736,000 | +76.9% | 631,490 | +88.4% | 0.04% | +15.8% |
| BIOAQ | Buy | BIOAMBER INC | $736,000 | +8077.8% | 15,639,774 | +73260.7% | 0.04% | +4300.0% |
| New | AMARIN CORP PLCput | $668,000 | – | 2,218 | +100.0% | 0.04% | – | |
| ONTX | Buy | ONCONOVA THERAPEUTICS INC | $668,000 | -20.7% | 799,160 | +42.4% | 0.04% | -48.1% |
| XLRN | New | ACCELERON PHARMA INC | $676,000 | – | 17,292 | +100.0% | 0.04% | – |
| XENE | Sell | XENON PHARMACEUTICALS INC | $656,000 | -29.5% | 134,000 | -59.3% | 0.04% | -54.1% |
| EIGR | Buy | EIGER BIOPHARMACEUTICALS INC | $634,000 | -7.3% | 64,380 | +31.4% | 0.04% | -38.7% |
| INSM | New | INSMED INC | $600,000 | – | 26,600 | +100.0% | 0.04% | – |
| NSPR | Sell | INSPIREMD INC | $508,000 | -8.5% | 487,588 | -88.7% | 0.03% | -41.2% |
| SNOA | New | SONOMA PHARMACEUTICALS INC | $510,000 | – | 138,400 | +100.0% | 0.03% | – |
| Buy | EDAP TMS SAput | $468,000 | +13.3% | 2,016 | +40.0% | 0.03% | -26.3% | |
| MNKD | New | MANNKIND CORPcall | $456,000 | – | 2,000 | +100.0% | 0.03% | – |
| New | ACCELERON PHARMA INCcall | $430,000 | – | 110 | +100.0% | 0.03% | – | |
| AXSM | New | AXSOME THERAPEUTICS INC | $398,000 | – | 162,318 | +100.0% | 0.02% | – |
| ONTXW | Buy | ONCONOVA THERAPEUTICS INC*w | $392,000 | +74.2% | 1,308,038 | +103.4% | 0.02% | +15.0% |
| ABEO | New | ABEONA THERAPEUTICS INC | $374,000 | – | 25,996 | +100.0% | 0.02% | – |
| SLDB | New | SOLID BIOSCIENCES INC | $376,000 | – | 50,000 | +100.0% | 0.02% | – |
| New | IMMUNOGEN INCput | $346,000 | – | 328 | +100.0% | 0.02% | – | |
| New | MARINUS PHARMACEUTICALS INCcall | $344,000 | – | 902 | +100.0% | 0.02% | – | |
| BPTH | Sell | BIO PATH HOLDINGS INC | $340,000 | -8.4% | 170,026 | -90.7% | 0.02% | -41.2% |
| FCEL | New | FUELCELL ENERGY INC | $316,000 | – | 182,800 | +100.0% | 0.02% | – |
| APDNW | Buy | APPLIED DNA SCIENCES INC*w | $324,000 | +32.8% | 1,297,648 | +102.0% | 0.02% | -13.6% |
| Buy | SOPHIRIS BIO INCput | $294,000 | +374.2% | 1,458 | +430.2% | 0.02% | +200.0% | |
| SGLBW | Buy | SIGMA LABS INC*w | $284,000 | +54.3% | 751,436 | +96.3% | 0.02% | 0.0% |
| EDAP | New | EDAP TMS SAadr | $282,000 | – | 121,200 | +100.0% | 0.02% | – |
| VTGN | Sell | VISTAGEN THERAPEUTICS INC | $266,000 | -88.7% | 286,972 | -86.4% | 0.02% | -92.5% |
| Sell | TRANSENTERIX INCput | $248,000 | -57.9% | 1,456 | -52.3% | 0.02% | -72.2% | |
| Sell | GALECTIN THERAPEUTICS INCput | $200,000 | -47.1% | 420 | -62.9% | 0.01% | -64.7% | |
| RXIIW | New | RXI PHARMACEUTICALS CORP*w | $176,000 | – | 393,044 | +100.0% | 0.01% | – |
| VICL | Sell | VICAL INC. | $174,000 | -65.4% | 119,664 | -56.5% | 0.01% | -78.3% |
| New | PTC THERAPEUTICS INCcall | $168,000 | – | 2,950 | +100.0% | 0.01% | – | |
| Buy | PROTHENA CORPORATION PLCcall | $148,000 | -83.6% | 480 | +100.0% | 0.01% | -89.0% | |
| BCLI | New | BRAINSTORM CELL THERAPEUTICS | $140,000 | – | 44,646 | +100.0% | 0.01% | – |
| AMRN | New | AMARIN CORP PLCadr | $122,000 | – | 40,600 | +100.0% | 0.01% | – |
| New | SOPHIRIS BIO INCcall | $116,000 | – | 580 | +100.0% | 0.01% | – | |
| CHEK | Sell | CHECK-CAP LTD | $78,000 | -91.1% | 150,560 | -85.1% | 0.01% | -93.8% |
| PSTI | New | PLURISTEM THERAPEUTICS INC | $76,000 | – | 55,280 | +100.0% | 0.01% | – |
| MDGS | Buy | MEDIGUS LTDadr | $60,000 | +25.0% | 47,212 | +27.8% | 0.00% | 0.0% |
| VNRX | New | VOLITIONRX LTD | $64,000 | – | 26,334 | +100.0% | 0.00% | – |
| NSPRZ | Buy | INSPIREMD INC*w | $60,000 | +50.0% | 3,996,834 | +99.5% | 0.00% | 0.0% |
| BIOC | Sell | BIOCEPT INC | $54,000 | -91.9% | 184,748 | -80.8% | 0.00% | -95.1% |
| BNTCW | New | BENITEC BIOPHARMA LTDcall | $42,000 | – | 175,386 | +100.0% | 0.00% | – |
| CYTXW | New | CYTORI THERAPEUTICS INCcall | $28,000 | – | 1,041,716 | +100.0% | 0.00% | – |
| New | PLURISTEM THERAPEUTICS INCput | $34,000 | – | 244 | +100.0% | 0.00% | – | |
| NSPRW | Buy | INSPIREMD INC*w | $36,000 | 0.0% | 1,822,746 | +52.7% | 0.00% | -33.3% |
| IMUCW | New | IMMUNOCELLULAR THERAPEUTICScall | $14,000 | – | 450,374 | +100.0% | 0.00% | – |
| Exit | IMMUNOMEDICS INCput | $0 | – | -305 | -100.0% | 0.00% | – | |
| New | VERSARTIS INCcall | $6,000 | – | 400 | +100.0% | 0.00% | – | |
| New | SELLAS LIFE SCIENCES GROUP INCcall | $8,000 | – | 3,036 | +100.0% | 0.00% | – | |
| AQB | New | AQUABOUNTY TECHNOLOGIES INC | $0 | – | 226 | +100.0% | 0.00% | – |
| HALO | New | HALOZYME THERAPEUTICS INC | $4,000 | – | 204 | +100.0% | 0.00% | – |
| ONSIZ | Exit | ONCOBIOLOGICS INC*w | $0 | – | -199,193 | -100.0% | 0.00% | – |
| KZIA | Exit | KAZIA THERAPEUTICS LTDadr | $0 | – | -366,668 | -100.0% | 0.00% | – |
| ONSIW | Exit | ONCOBIOLOGICS INC*w | $0 | – | -89,644 | -100.0% | 0.00% | – |
| CYTXW | Exit | CYTORI THERAPEUTICS INC*w | $0 | – | -1,028,634 | -100.0% | -0.00% | – |
| IMUCW | Exit | IMMUNOCELLULAR THERAPEUTICS*w | $0 | – | -392,702 | -100.0% | -0.00% | – |
| OASMY | Exit | OASMIA PHARMACEUTICALadr | $0 | – | -19,000 | -100.0% | -0.00% | – |
| Exit | MANNKIND CORPcall | $0 | – | -116 | -100.0% | -0.00% | – | |
| Exit | AETERNA ZENTARIS INCcall | $0 | – | -138 | -100.0% | -0.00% | – | |
| Exit | AGENUS INCput | $0 | – | -116 | -100.0% | -0.00% | – | |
| CFRX | Exit | CONTRAFECT CORP. | $0 | – | -34,333 | -100.0% | -0.00% | – |
| BNTCW | Exit | BENITEC BIOPHARMA LTD*w | $0 | – | -90,193 | -100.0% | -0.00% | – |
| IMMP | Exit | IMMUTEP LTDadr | $0 | – | -21,500 | -100.0% | -0.00% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS INC | $0 | – | -16,705 | -100.0% | -0.00% | – |
| Exit | AETERNA ZENTARIS INCput | $0 | – | -264 | -100.0% | -0.00% | – | |
| Exit | ACHILLION PHARMACEUTICALS INCput | $0 | – | -174 | -100.0% | -0.01% | – | |
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -10,000 | -100.0% | -0.01% | – | |
| TNDM | Exit | TANDEM DIABETES CARE INC. | $0 | – | -27,487 | -100.0% | -0.01% | – |
| EGLTQ | Exit | EGALET CORP | $0 | – | -73,792 | -100.0% | -0.01% | – |
| Exit | ADVAXIS INCcall | $0 | – | -270 | -100.0% | -0.01% | – | |
| RDHL | Exit | REDHILL BIOPHARMA LTDads | $0 | – | -21,322 | -100.0% | -0.01% | – |
| Exit | ANTHERA PHARMACEUTICALS INCput | $0 | – | -658 | -100.0% | -0.01% | – | |
| RTTR | Exit | RITTER PHARMACEUTICALS INC | $0 | – | -357,781 | -100.0% | -0.01% | – |
| SPHS | Exit | SOPHIRIS BIO INC | $0 | – | -55,907 | -100.0% | -0.01% | – |
| JAGX | Exit | JAGUAR HEALTH INC | $0 | – | -1,045,741 | -100.0% | -0.01% | – |
| ABIO | Exit | ARCA BIOPHARMA INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
| Exit | GALENA BIOPHARMA INCcall | $0 | – | -7,602 | -100.0% | -0.02% | – | |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -5,629 | -100.0% | -0.02% | – |
| ONCS | Exit | ONCOSEC MEDICAL INC | $0 | – | -153,137 | -100.0% | -0.02% | – |
| Exit | REGENXBIO INCcall | $0 | – | -81 | -100.0% | -0.02% | – | |
| VTVT | Exit | VTV THERAPEUTICS INCcl a | $0 | – | -44,500 | -100.0% | -0.02% | – |
| RXIIW | Exit | RXI PHARMACEUTICALS CORP*w | $0 | – | -2,100,797 | -100.0% | -0.02% | – |
| Exit | ACHILLION PHARMACEUTICALS INCcall | $0 | – | -992 | -100.0% | -0.03% | – | |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -0.03% | – |
| YTEN | Exit | YIELD10 BIOSCIENCE INC | $0 | – | -215,250 | -100.0% | -0.04% | – |
| Exit | CLOVIS ONCOLOGY INCcall | $0 | – | -67 | -100.0% | -0.04% | – | |
| SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -125,000 | -100.0% | -0.04% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -89,350 | -100.0% | -0.05% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -115,462 | -100.0% | -0.06% | – |
| IDRA | Exit | IDERA PHARMACEUTICALS INC | $0 | – | -307,987 | -100.0% | -0.06% | – |
| GALE | Exit | GALENA BIOPHARMA INC | $0 | – | -2,623,610 | -100.0% | -0.06% | – |
| Exit | TESARO INCcall | $0 | – | -85 | -100.0% | -0.06% | – | |
| Exit | AMAG PHARMACEUTICALS INCcall | $0 | – | -553 | -100.0% | -0.07% | – | |
| BPMX | Exit | BIOPHARMX CORP | $0 | – | -6,713,756 | -100.0% | -0.07% | – |
| FCSC | Exit | FIBROCELL SCIENCE INC | $0 | – | -1,128,588 | -100.0% | -0.07% | – |
| CPST | Exit | CAPSTONE TURBINE CORP. | $0 | – | -983,787 | -100.0% | -0.07% | – |
| TSRO | Exit | TESARO INC | $0 | – | -9,700 | -100.0% | -0.07% | – |
| Exit | AIMMUNE THERAPEUTICS INCput | $0 | – | -222 | -100.0% | -0.08% | – | |
| Exit | TESARO INCput | $0 | – | -104 | -100.0% | -0.08% | – | |
| IPCI | Exit | INTELLIPHARMACEUTICS INTERNATIONAL INC | $0 | – | -1,083,637 | -100.0% | -0.08% | – |
| Exit | AGENUS INCcall | $0 | – | -2,860 | -100.0% | -0.08% | – | |
| Exit | AXOVANT SCIENCES LTDput | $0 | – | -1,848 | -100.0% | -0.09% | – | |
| HTBX | Exit | HEAT BIOLOGICS INC | $0 | – | -2,615,123 | -100.0% | -0.09% | – |
| Exit | AXOVANT SCIENCES LTDcall | $0 | – | -2,146 | -100.0% | -0.10% | – | |
| DERM | Exit | DERMIRA INC | $0 | – | -45,304 | -100.0% | -0.12% | – |
| AMAG | Exit | AMAG PHARMACEUTICALS INC | $0 | – | -118,864 | -100.0% | -0.14% | – |
| Exit | MANNKIND CORPput | $0 | – | -8,169 | -100.0% | -0.17% | – | |
| HSGX | Exit | HISTOGENICS CORP. | $0 | – | -955,060 | -100.0% | -0.18% | – |
| Exit | DERMIRA INCput | $0 | – | -766 | -100.0% | -0.19% | – | |
| Exit | AMAG PHARMACEUTICALS INCput | $0 | – | -1,822 | -100.0% | -0.22% | – | |
| Exit | INTERCEPT PHARMACEUTICALS INCcall | $0 | – | -447 | -100.0% | -0.24% | – | |
| ABBV | Exit | ABBVIE INC | $0 | – | -27,559 | -100.0% | -0.24% | – |
| Exit | GILEAD SCIENCES INCcall | $0 | – | -454 | -100.0% | -0.30% | – | |
| Exit | SAGE THERAPEUTICS INCput | $0 | – | -259 | -100.0% | -0.39% | – | |
| Exit | GW PHARMACEUTICALS PLCput | $0 | – | -353 | -100.0% | -0.42% | – | |
| Exit | RADIUS HEALTH INCcall | $0 | – | -1,536 | -100.0% | -0.44% | – | |
| Exit | SPDR S&P BIOTECHcall | $0 | – | -656 | -100.0% | -0.51% | – | |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -110,827 | -100.0% | -0.52% | – |
| Exit | SAGE THERAPEUTICS INCcall | $0 | – | -350 | -100.0% | -0.52% | – | |
| Exit | IONIS PHARMACEUTICALS INCput | $0 | – | -1,230 | -100.0% | -0.56% | – | |
| Exit | IONIS PHARMACEUTICALS INCcall | $0 | – | -1,429 | -100.0% | -0.66% | – | |
| Exit | VERTEX PHARMACEUTICALS INCput | $0 | – | -486 | -100.0% | -0.66% | – | |
| Exit | ABBVIE INCput | $0 | – | -776 | -100.0% | -0.68% | – | |
| Exit | BLUEBIRD BIO INCput | $0 | – | -485 | -100.0% | -0.79% | – | |
| Exit | HALOZYME THERAPEUTICS INCcall | $0 | – | -4,950 | -100.0% | -0.91% | – | |
| Exit | ALNYLAM PHARMACEUTICALS INCcall | $0 | – | -941 | -100.0% | -1.09% | – | |
| Exit | CIGNA CORPcall | $0 | – | -670 | -100.0% | -1.24% | – | |
| Exit | JUNO THERAPEUTICS INCcall | $0 | – | -3,003 | -100.0% | -1.25% | – | |
| Exit | BRISTOL MYERS SQUIBB COcall | $0 | – | -4,225 | -100.0% | -2.36% | – | |
| Exit | SPDR S&P 500call | $0 | – | -3,000 | -100.0% | -4.88% | – | |
| Exit | BLUEBIRD BIO INCcall | $0 | – | -4,250 | -100.0% | -6.89% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.